KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Baxter International (BAX) Operating Income (2016 - 2024)

Baxter International (BAX) has disclosed Operating Income for 16 consecutive years, with $959.0 million as the latest value for Q4 2024.

  • Quarterly Operating Income rose 48.45% to $959.0 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $3.2 billion through Dec 2024, up 354.03% year-over-year, with the annual reading at -$308.0 million for FY2025, 2300.0% down from the prior year.
  • Operating Income for Q4 2024 was $959.0 million at Baxter International, down from $1.0 billion in the prior quarter.
  • The five-year high for Operating Income was $1.0 billion in Q3 2024, with the low at -$2.9 billion in Q3 2022.
  • Average Operating Income over 5 years is $205.9 million, with a median of $360.5 million recorded in 2020.
  • The sharpest move saw Operating Income tumbled 1456.52% in 2022, then soared 6164.71% in 2024.
  • Over 5 years, Operating Income stood at $406.0 million in 2020, then crashed by 94.33% to $23.0 million in 2021, then crashed by 1456.52% to -$312.0 million in 2022, then surged by 307.05% to $646.0 million in 2023, then skyrocketed by 48.45% to $959.0 million in 2024.
  • According to Business Quant data, Operating Income over the past three periods came in at $959.0 million, $1.0 billion, and $1.0 billion for Q4 2024, Q3 2024, and Q2 2024 respectively.